First trimester Down syndrome screening: Public health implications

Seminars in Perinatology

Volumn 29, Issue 4, 2005, Pages 267-271

  Fuchs, Karin M ^a   Peipert, Jeffrey F ^a,b  

^a BROWN UNIVERSITY   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

Aneuploidy; Down syndrome; Nuchal translucency; Prenatal screening; Trisomy 21; Ultrasound

Indexed keywords

CHORIONIC GONADOTROPIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

BLOOD LEVEL; CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; PATIENT COUNSELING; PATIENT EDUCATION; PRENATAL CARE; PRENATAL SCREENING; PRIORITY JOURNAL; QUALITY CONTROL; SCREENING; SECOND TRIMESTER PREGNANCY; STATISTICAL SIGNIFICANCE; TRISOMY 21;

CHORIONIC GONADOTROPIN; DOWN SYNDROME; FEMALE; FETAL DISEASES; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PATIENT EDUCATION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; PUBLIC HEALTH;

EID: 23644446888     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2005.05.003     Document Type: Conference Paper

References (17)

1. F.D. Malone, M.E. D'Alton First trimester sonographic screening for Down syndrome Obstet Gynecol 102 2003 1066 1079
2. J.R. Biggio, T.C. Morris, J. Owen An outcome analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years Am J Obstet Gynecol 190 2004 721 729
3. F.D. Malone, R.L. Berkowitz, J.A. Canick First trimester screening for aneuploidy research or standard of care? Am J Obstet Gynecol 182 2000 490 496
4. F. Scott, A. Boogert, M. Sinosich Establishment and application of a normal range for nuchal translucency across the first trimester Prenat Diagn 16 1996 629 634
5. K.H. Nicolaides, V. Heath, S. Cicero Increased fetal nuchal translucency at 11-14 weeks Prenat Diagn 22 2002 308 315
6. K.H. Nicolaides Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities Am J Obstet Gynecol 191 2004 45 67
7. L. Dugoff, J. Hobbins, F.D. Malone First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications a population-based screening study (the FASTER Trial) Am J Obstet Gynecol 191 2004 1446 1451
8. N.J. Wald, C. Rodeck, A.K. Hackshaw First and second trimester antenatal screening for Down's syndrome the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) J Med Screen 10 2003 56 104
9. F.D. Malone, N.J. Wald, J.A. Canick First- and second-trimester evaluation of risk (FASTER) trial principle results of the NICHD multicenter Down syndrome screening study Am J Obstet Gynecol 189 2003 S56
10. F.D. Malone, N.J. Wald, J.A. Canick Use of overall population, center-specific, and sonographer-specific nuchal translucency medians in Down syndrome screening which is best? Am J Obstet Gynecol 189 2003 S232
11. G. Monni, M.A. Zoppi, R.M. Ibba Results of measurements of nuchal translucency ultrasound before and after training Lancet 350 1997 1631
12. G.E. Palomaki, G.J. Knight, J. McCarthy Maternal serum screening for Down syndrome in the United States a 1995 survey Am J Obstet Gynecol 176 1997 1046 1051
13. W.P. Frisbie, S. Echevarria, R.A. Hummer Prenatal care utilization among non-Hispanic whites, African-Americans, and Mexican-Americans Matern Child Health J 5 2001 21 33
14. R.E. Rowe, J. Garcia, L.L. Davidson Social and ethnic inequalities in the offer and uptake of prenatal screening and diagnosis in the UK a systematic review Public Health 118 2004 177 189
15. J.F. Egan, L.M. Kaminsky, M.E. DeRoche Antenatal Down syndrome screening in the United States in 2001 a survey of maternal-fetal medicine specialists Am J Obstet Gynecol 187 2002 1230 1234
16. R.A. Kadir, D.L. Economides The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome Ultrasound Obstet Gynecol 9 1997 244 247
17. A.K. Hackshaw, N.J. Wald Inaccurate estimation of risk in second trimester serum screening for Down syndrome among women who have already had first trimester screening Prenat Diagn 21 2001 741 746